Гончарова Олеся Алексеевна
12 works · 4 citations · h-index 1
Top works
- Toxicity and safety of the combination of lenvatinib with pembrolizumab in patients with advanced renal cell cancer: The Russian phase IV observational study
- Causes of resistance to PARP inhibitors and ways to overcome it. Case report of aggressive BRCA-related breast cancer
- Efficacy of the combination of lenvatinib with pembrolizumab in patients with advanced renal cell carcinoma
- Results of an international, double-blind, randomized, phase III clinical trial to compare the efficacy and safety of a biosimilar pertuzumab (BCD-178) with reference pertuzumab in patients with HER2-positive breast cancer
- Эффективность и безопасность ленватиниба с пембролизумабом при распространенном почечноклеточном раке в реальной практике: обновленные данные российского наблюдательного исследования
- Real-world efficacy and safety of lenvatinib plus pembrolizumab in advanced renal cell carcinoma: Updated data from a Russian observational study
- Clinical and prognostic characteristics of BRCA1/2-associated breast cancer depending on the type of mutation: estrogen signaling pathway and secondary tumors
- Новые возможности терапии метастатического HER2-позитивного рака молочной железы с лептоменингеальным поражением
- New treatment options for HER2-positive metastatic breast cancer with leptomeningeal metastases
- Efficacy and safety of lenvatinib plus pembrolizumab in patients with advanced renal cell carcinoma and venous tumor thrombus: Results from the first analysis of the PELET trial.
- USTIFICATION FOR IDENTIFYING SELENODEFITSITNYH AREAS IN UKRAINE AND ORGANIZATIONS CORRECTIVE MEASURES